PET血管活性评分(PETVAS)对大动脉炎患者炎症活动性定性与定量评估的性能
该研究分析了54例大动脉炎(TAK)患者的64次PET/CT扫描,以医师整体评估定性、ITAS-2010定量炎症活动性,比较PETVAS与SUVmax、炎症生物标志物(CRP、ESR、PTX-3)及ITAS-2010的性能。结果显示PETVAS与PTX-3的ROC曲线下面积及Youden指数高于SUVmax、CRP、ESR和ITAS-2010,且与ITAS-2010的Spearman相关系数更高;随访中PETVAS与PTX-3的变化趋势与临床进展/缓解评估的相关性更紧密。
要点
- 活动期TAK患者的CRP、ESR、PTX-3、SUVmax、PETVAS及ITAS-2010均显著高于非活动期患者。
- PETVAS与PTX-3的ROC曲线下面积和Youden指数高于SUVmax、CRP、ESR及ITAS-2010。
- PETVAS与PTX-3同ITAS-2010的Spearman相关系数高于其他指标,随访变化趋势与临床进展/缓解评估相关性更紧密。
核心结论
- 在TAK评估中,PETVAS在定性与定量评估方面优于区域性SUVmax。
- 与CRP和ESR相比,炎症生物标志物PTX-3显示出更好的定性性能,并与PETVAS和ITAS-2010有更高的相关性。
- 这些发现提示,使用PETVAS和PTX-3替代SUVmax和CRP/ESR在TAK临床评估中具有潜在优势。
研究设计与样本
- 研究分析了来自54例TAK患者的64次PET/CT扫描。
- 炎症活动性由医师整体评估定性确定,并由ITAS-2010评分定量确定。
- SUVmax和PETVAS通过共识审阅获得,并测量了CRP、ESR和PTX-3水平。
- 定性诊断性能与定量相关性分别采用ROC曲线和Spearman相关系数进行比较。
主要发现
- 活动期患者的CRP、ESR、PTX-3、SUVmax、PETVAS及ITAS-2010评分均显著高于非活动期患者。
- PETVAS与PTX-3的ROC曲线下面积和Youden指数高于SUVmax、CRP、ESR和ITAS-2010。
- 在所有患者中或活动组内,PETVAS与PTX-3同ITAS-2010的Spearman相关系数高于其他指标。
- 随访期间PETVAS与PTX-3的变化趋势与临床进展/缓解评估的相关性比其他指标更紧密。
关键数值与推荐
- 活动性由医师整体评估定性确定,并由ITAS-2010评分定量确定。
- PETVAS与PTX-3的ROC曲线下面积和Youden指数高于SUVmax、CRP、ESR和ITAS-2010。
- PETVAS与PTX-3同ITAS-2010的Spearman相关系数高于其他指标。
临床怎么用
- 作者认为,使用PETVAS和PTX-3替代SUVmax和CRP/ESR在TAK临床评估中具有潜在优势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the performance of PET vascular activity score (PETVAS) in comparison with SUVmax, inflammatory biomarkers and ITAS-2010 score in a cohort of TAK patients. METHODS: Sixty-four PET/CT scans acquired from 54 TAK patients were analyzed. The inflammatory activity was qualitatively determined by physician's global assessment and quantitatively determined by ITAS-2010 score. SUVmax and PETVAS were acquired by consensus review. Levels of the inflammatory biomarkers C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and pentraxin-3 (PTX-3) were measured. Performance of the qualitative diagnoses and the quantitative correlation were, respectively, compared by receiver operating characteristic (ROC) curve and Spearman correlation coefficient. RESULTS: The biomarkers (CRP, ESR, PTX-3), PET uptake values (SUVmax, PETVAS), and ITAS-2010 scores were all significantly higher in active patients than in non-active ones. The area under the ROC curve and Youden Index of PETVAS and PTX-3 were higher than those of SUVmax, CRP, ESR, and ITAS-2010. PETVAS and PTX-3 resulted in a higher Spearman correlation coefficient with ITAS-2010 than other criteria, either among all patients or within the active group. Alteration trends of PETVAS and PTX-3 during follow-up showed a tighter correlation with clinical progression/remission assessment than other criteria. CONCLUSIONS: In TAK evaluation, PETVAS is superior for qualitative and quantitative assessment, compared with the regional SUVmax. Compared to CRP and ESR, inflammatory biomarker PTX-3 shows better qualitative performance and a higher correlation with PETVAS and ITAS-2010. These findings indicate that the use of PETVAS and PTX-3, instead of SUVmax and CRP/ESR, has potential advantages in the clinical evaluation of TAK.
引用
- Kang F, Han Q, Zhou X, et al. Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients. Eur J Nucl Med Mol Imaging. 2020. PMID: 32567005. doi:10.1007/s00259-020-04871-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。